Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

Part of paid clinical trials in Swiftwater, Pennsylvania.

Sponsor
Sanofi
Study ID
NCT06968975
Status
Recruiting
Apply to this trial

Conditions

  • Polyneuropathy, Inflammatory Demyelinating, Chronic

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three months of treatment with standard of care therapy. The study is expected to last two years. Enrollment is expected to continue for one year. Depending on when the participant is enrolled, a participant can be followed for between one and two years, through the end of study, approximately two years after the study starts.

Key Dates

Start date
Apr 11, 2025
Status verified
Jun 2025
Primary completion
May 17, 2027
Completion
May 17, 2027

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

I-RODS score at baseline [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Investigational SiteSwiftwaterPennsylvania18370-0187-

Find similar trials in Swiftwater, PA

By research site
Investigational Site· Swiftwater, PA

Related Studies